Clinical Trials Browser

Terminated × Central Nervous System Neoplasms × Erlotinib Hydrochloride × Clear all

NCT00227032 2012-03-06

Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme

Phase 1 Terminated

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma